Marcus had been told his testosterone was “normal” for three years running. Three years of fatigue that made getting off the couch feel like a CrossFit workout. Three years of a libido that had gone from roaring fire to pilot light. Three years of watching his body composition drift the wrong direction despite doing most things right. Then he switched doctors and requested a full male hormone panel — not just total testosterone, but the whole picture. What came back wasn’t “normal” at all. His free testosterone was in the basement, his estradiol was elevated, and his SHBG was so high it was essentially locking up whatever testosterone his body was producing. The number on the standard test looked fine. The underlying reality was a hormonal disaster.
That gap — between what a surface-level test shows and what’s actually happening in the body — is why understanding the male hormone panel matters. Not because anyone’s going to self-prescribe or turn themselves into a walking clinical trial, but because self-advocacy requires knowing what to ask for in the first place. The healthcare system, on its best day, runs a 15-minute appointment and orders the minimum number of tests to check a box. Real answers require knowing which questions to ask.
This is that guide. Every marker that belongs on a comprehensive male hormone panel, why it matters, what optimal looks like versus “normal,” and how often testing should happen. No pseudoscience, no supplement pushing. Just the information a doctor should have given but probably didn’t.
Why “Normal” Testosterone Is Often a Lie
This is not medicine. This is checkbox completion.
The Endocrine Society’s 2018 clinical practice guidelines (Bhasin et al., 2018) represent the most comprehensive evidence-based framework currently available for testosterone evaluation in men. The guidelines acknowledge that symptoms of hypogonadism — fatigue, reduced libido, decreased muscle mass, cognitive fog, mood disruption — can occur at testosterone levels well within the “normal” reference range, particularly when SHBG is elevated or estradiol is disproportionately high. The guidelines recommend confirming low testosterone with at least two morning measurements before any clinical decision-making, and explicitly note that isolated total testosterone is insufficient for a complete clinical picture.
The practical implication: a single total testosterone result above 300, in a symptomatic man, is not the end of the conversation. It’s the beginning.
There’s also the issue of population decline. Multiple studies, including a 2007 analysis published in the Journal of Clinical Endocrinology and Metabolism, found testosterone levels in American men declining substantially over the past several decades — independent of aging. A 60-year-old man in 2000 had higher testosterone than a 60-year-old man in 1990. Something environmental, behavioral, or both is suppressing male hormonal function across the board. The “normal” range anyone gets evaluated against is increasingly a normal derived from a population that’s itself hormonally compromised.
The Complete Male Hormone Panel: Every Marker Explained
A genuine comprehensive male hormone panel includes nine core markers. Some labs will resist ordering all of them. Some physicians will call several unnecessary. They’re wrong, and understanding why each marker matters helps push back intelligently.
Total Testosterone is the headline number — the total amount of testosterone circulating in the blood, both bound and unbound. Standard reference range: 300–1000 ng/dL. Optimal functional range for most men seeking performance and wellbeing: 600–900 ng/dL. Total testosterone alone doesn’t reveal how much is biologically active, which is why it’s a starting point, not a conclusion. Testing should always happen in the morning (7–10 AM), fasted, since testosterone follows a diurnal rhythm and drops by 20–30% over the course of the day. Testing in the afternoon produces an artificially deflated number.
Free Testosterone is what actually matters biologically. Only 1–3% of circulating testosterone is “free” — unbound to proteins and available to enter cells and exert effects. The rest is bound to sex hormone-binding globulin (about 45%) or albumin (about 54%). Albumin-bound testosterone is loosely bound and considered bioavailable, but it’s free testosterone that drives most of what men associate with hormonal vitality. Reference range: 50–210 pg/mL, though optimal is generally considered above 100 pg/mL for men symptomatic at the low end. Free testosterone is typically calculated from total testosterone, SHBG, and albumin — direct measurement via equilibrium dialysis is more accurate but rarely ordered outside specialist settings.
Sex Hormone-Binding Globulin (SHBG) is a glycoprotein produced primarily in the liver that binds to sex hormones, particularly testosterone and estradiol. High SHBG effectively inactivates testosterone regardless of how much the body is producing. Reference range: 16–55 nmol/L. Men with SHBG above 50 may have total testosterone that looks acceptable while free testosterone is critically low — exactly what happened with Marcus at the beginning of this article. SHBG increases with age, with caloric restriction, with hyperthyroidism, and with excessive alcohol consumption. It decreases with insulin resistance, obesity, and hypothyroidism. Understanding SHBG level reveals something important about lifestyle and metabolic state, not just hormonal status.
Estradiol (E2) is the primary estrogen in men, and yes, men produce estrogen. It’s essential — it protects bone density, cardiovascular function, and cognitive health. The problem is excess. When testosterone aromatizes (converts) to estradiol at high rates, typically due to excess body fat or genetic variation in aromatase activity, the ratio shifts unfavorably. Symptoms of elevated estradiol include water retention, reduced libido, emotional volatility, and gynecomastia. Reference range: 10–40 pg/mL. Optimal for most men: 20–30 pg/mL. The ratio of testosterone to estradiol matters as much as absolute levels — a man with 900 ng/dL testosterone and 45 pg/mL estradiol has a different hormonal profile than a man with 600 ng/dL testosterone and 20 pg/mL estradiol, and not necessarily a better one.
Luteinizing Hormone (LH) is produced by the pituitary gland and signals the testes to produce testosterone. If LH is high and testosterone is low, the problem sits in the testes — they’re receiving the signal but not responding adequately (primary hypogonadism). If LH is low and testosterone is low, the problem sits higher up — the hypothalamic-pituitary axis isn’t sending the signal (secondary hypogonadism). This distinction matters enormously for treatment approaches. Reference range: 1.7–8.6 IU/L. Men on testosterone replacement therapy will typically have suppressed LH (their pituitary has stopped signaling because exogenous testosterone has closed the feedback loop), which is why this marker is most useful in baseline and diagnostic contexts rather than ongoing optimization monitoring.
Follicle-Stimulating Hormone (FSH) also comes from the pituitary and regulates sperm production. Low FSH alongside low LH and low testosterone is a classic pattern of secondary hypogonadism. Very high FSH with low testosterone suggests testicular failure. For men concerned about fertility, FSH is not optional — it’s central to understanding reproductive capacity. Reference range: 1.5–12.4 IU/L.
Prolactin is most commonly discussed in women, but elevated prolactin in men (hyperprolactinemia) is a significant and underdiagnosed cause of low testosterone and sexual dysfunction. A prolactin-secreting pituitary adenoma (prolactinoma) is not rare — estimated to affect roughly 1 in 10,000 people, and many cases go undiagnosed for years. Elevated prolactin suppresses GnRH, which then suppresses LH and FSH, which then suppresses testosterone production. Reference range: 2–18 ng/mL for men. Any result above 25 ng/mL warrants further investigation. Routine inclusion of prolactin on a male hormone panel catches this clinically important finding that would otherwise be missed entirely.
DHEA-Sulfate (DHEA-S) is a precursor hormone produced by the adrenal glands that converts to both testosterone and estrogen. It’s one of the most abundant circulating hormones in young adults, and it declines dramatically with age — peak at 20–30 years, roughly 80% lower by age 70. Reference range varies significantly by age, but for men aged 30–50, typical range is 80–560 mcg/dL. DHEA-S provides information about adrenal reserve and is a useful context marker — very low DHEA-S in a young man suggests adrenal dysfunction or significant chronic stress. Very high DHEA-S alongside other androgen excess markers warrants investigation for adrenal pathology.
Cortisol (AM) is the stress hormone produced by the adrenal cortex, and it belongs on a comprehensive male hormone panel for a specific reason: cortisol and testosterone exist in a dynamic tension. Chronically elevated cortisol from unrelenting stress suppresses testosterone production through multiple mechanisms, including direct inhibition of testicular Leydig cell function and suppression of gonadotropin-releasing hormone (GnRH) from the hypothalamus. A morning cortisol measurement (collected at the peak of the diurnal cortisol rhythm, ideally 7–9 AM) provides a snapshot of adrenal function. Reference range: 6–23 mcg/dL. A man with low testosterone and an elevated AM cortisol carries a different clinical picture than a man with low testosterone and normal cortisol — the former’s situation is likely significantly driven by stress physiology.
The Male Hormone Panel Checklist Framework
The following framework structures how to approach ordering, interpreting, and acting on male hormone panel results. Think of it as a systematic guide from pre-test preparation through to decision-making.
Phase 1: Pre-Test Preparation. The single biggest variable under anyone’s control is timing. Testosterone is highest in the morning and drops throughout the day. Testing at 8 AM versus 3 PM can shift the result by 20–30%. Always draw blood between 7 and 10 AM. Fast for at least 8 hours before the draw — food, and particularly carbohydrates, can transiently affect hormone levels. Don’t test after a hard workout the previous day; acute intense exercise can temporarily suppress testosterone. Don’t test during a period of acute illness or extreme stress. The goal is a representative baseline, not a worst-case-scenario snapshot.
Phase 2: The Panel Order. Insist on all nine markers for the baseline: total testosterone, free testosterone (calculated), SHBG, estradiol (sensitive assay — not standard), LH, FSH, prolactin, DHEA-S, and AM cortisol. The sensitive estradiol assay matters — the standard estradiol assay used for women isn’t accurate at the lower levels typical in men. Specifically request “estradiol, sensitive” or “E2, LC/MS-MS” where the methodology can be specified. At minimum, specify that the result needs to be accurate at levels below 40 pg/mL.
Phase 3: The Interpretation Sequence. Don’t start with total testosterone. Start with the pattern. High LH + Low T = primary issue (testes). Low LH + Low T = secondary issue (hypothalamus/pituitary). Elevated prolactin = investigate pituitary. High SHBG + Low free T despite acceptable total T = SHBG is the problem. High E2 relative to T = aromatization issue. Elevated AM cortisol + Low T = stress physiology driving suppression. The pattern tells you where to look next.
Phase 4: The Action Threshold. Don’t make any clinical decisions based on a single test. The Bhasin 2018 guidelines explicitly recommend confirmatory testing before diagnosis. Two tests, taken on separate mornings within 4 weeks, provide much better signal than one. Biological variation in testosterone from day to day is significant — up to 30% variability is normal even in healthy men.
Phase 5: The Documentation Habit. Keep independent records. Don’t assume a doctor will track trends across multiple years. A spreadsheet with date, time of draw, fasting status, and all nine values gives a longitudinal view that’s extraordinarily useful for understanding trajectory. Trends matter more than individual data points.
How Often Should You Test?
Testing frequency depends on where someone sits in the optimization process. Three distinct phases, each with different appropriate cadences.
Baseline Phase (All Men, Starting Now): Anyone who’s never had a comprehensive male hormone panel should get one this year regardless of how they feel. The purpose is establishing a personal baseline — the numbers while relatively healthy and functioning. That baseline becomes the reference point for everything that follows. Annual testing maintains this reference over time and catches slow changes in hormonal status that might otherwise accumulate unnoticed for years.
Optimization Phase (Active Intervention): Anyone who’s identified a hormonal issue and is making lifestyle changes — improving sleep, managing stress, adjusting body composition, changing diet — should retest every 3 months. Frequent enough to see whether interventions are working, without being so frequent that noise gets chased instead of signal. Hormonal changes from lifestyle interventions take 8–12 weeks to fully manifest in bloodwork, which is why quarterly testing makes sense during active optimization.
TRT Phase (If Applicable): Men who have initiated testosterone replacement therapy with medical supervision should test every 6–8 weeks during the initial dose-finding period, then every 3–6 months once stable. The monitoring panel during TRT typically adds hematocrit/hemoglobin (testosterone increases red blood cell production, which can increase clotting risk if hematocrit rises above 52–54%), PSA (prostate-specific antigen, relevant for men over 40), and may deprioritize LH/FSH (which will be suppressed by exogenous testosterone). Estradiol management becomes more critical during TRT, since additional testosterone means additional substrate for aromatization.
One important note: resist the temptation to test too frequently. Testing every 4–6 weeks creates a situation where noise gets treated as signal. Hormone levels fluctuate meaningfully day to day and week to week based on sleep quality, stress, hydration, activity level, and dozens of other variables. Monthly testing produces a constant sense of crisis or constant optimization when what’s actually happening is normal biological variation.
Where to Get Tested: Working the System
Option 1: Push the physician. Come prepared with a list of symptoms and the Bhasin 2018 guidelines reference. Ask for the complete panel by name. If certain tests get called unnecessary, ask why specifically. A physician who gives a thoughtful, evidence-based reason for excluding a marker is practicing good medicine. One who says “we don’t usually test that” without further explanation is following administrative habit, not clinical judgment. A second opinion is always available.
Option 2: Testosterone clinics and men’s health specialists. The past decade has seen a significant expansion in clinics specifically oriented toward male hormone optimization — Defy Medical, Marek Health, and various concierge medicine practices are examples. These clinics are generally more willing to run comprehensive panels, employ physicians familiar with optimization-level interpretation (not just disease-diagnosis interpretation), and provide ongoing monitoring. The trade-off is cost — most operate outside standard insurance coverage.
Option 3: Direct-to-consumer lab ordering. In most US states, lab work can be ordered directly through services like Ulta Lab Tests, LabCorp’s patient direct program, or Quest’s patient portal without a physician order. A comprehensive male hormone panel typically costs $100–250 out of pocket through these channels, significantly less than a specialist visit plus labs billed through insurance with deductibles. Results come back directly, then get brought to a physician for interpretation and clinical decision-making. The limitation: without physician oversight, clinical context that changes how results should be interpreted can get missed.
Common Hormonal Patterns and What They Mean
Understanding the most common diagnostic patterns that emerge from male hormone panels turns results interpretation into a framework rather than staring at numbers without context.
Pattern 1: High SHBG + Acceptable Total T + Low Free T. This is the Marcus pattern from the opening. The man who tests “normal” on standard labs but feels hormonally compromised. The mechanism is typically age-related increase in SHBG (rises about 1–2% per year after 40), liver dysfunction, hyperthyroidism, or excessive alcohol or caloric restriction. Clinical approach focuses on addressing the underlying driver of elevated SHBG and potentially using bioavailable testosterone as the more relevant metric. In some cases, treatment targeting SHBG elevation directly (proviron in certain clinical contexts, or lifestyle interventions that reduce SHBG like zinc and resistance training) can meaningfully improve free testosterone without any additional interventions.
Pattern 2: Low T + High E2 + High Body Fat. The classic aromatization pattern. Adipose tissue contains high concentrations of aromatase, the enzyme that converts testosterone to estradiol. More body fat → more aromatization → higher estradiol → higher estradiol suppresses LH via negative feedback → lower testosterone production. A self-reinforcing cycle. The clinical priority here is body composition — fat loss reduces aromatization and improves the T:E2 ratio through the most sustainable mechanism available. Targeting 10–15% body fat rather than 20–25% can produce clinically meaningful improvements in testosterone and estradiol without any other intervention.
Pattern 3: Low T + High LH/FSH. Primary hypogonadism — the testes are receiving the signal but can’t respond. Causes include Klinefelter syndrome, orchitis (testicular inflammation from infection), testicular torsion history, chemotherapy, radiation, or varicocele. This pattern typically requires urological evaluation and is less responsive to lifestyle optimization alone — the machinery for producing testosterone is compromised regardless of how well the rest of the system functions.
Pattern 4: Low T + Low LH/FSH + High Prolactin. Classic hyperprolactinemia pattern. Prolactin is suppressing the entire HPG axis. The priority is imaging — an MRI of the pituitary to rule out a prolactinoma. Small prolactinomas are often medically managed with dopamine agonists (cabergoline, bromocriptine) with excellent outcomes. Optimizing testosterone lifestyle factors shouldn’t start until this is ruled out, because the downstream cascade won’t improve while prolactin remains elevated.
Pattern 5: Low-Normal T + High AM Cortisol. The stress-suppressed pattern. The HPA (hypothalamic-pituitary-adrenal) axis and the HPG (hypothalamic-pituitary-gonadal) axis share regulatory resources. Chronic physiological stress — sleep deprivation, overtraining, caloric restriction, psychological stress — elevates cortisol and suppresses the HPG axis. Men in this pattern often see meaningful testosterone improvement from stress reduction interventions (sleep prioritization, training load management, meditation, caloric adequacy) before any hormone-specific interventions become necessary.
Lifestyle Variables That Move the Needle
Before any conversation about clinical intervention opens, lifestyle optimization is both the ethical first step and often the most effective one. The evidence base for lifestyle-mediated testosterone optimization is substantial and underappreciated.
Sleep is probably the most powerful single lever available. A landmark study published in JAMA in 2011 (Leproult and Van Cauter) found that restricting sleep to 5 hours per night for one week reduced testosterone levels by 10–15% in healthy young men — the equivalent of 10–15 years of aging. The majority of daily testosterone release occurs during sleep, specifically during the first few REM cycles. Consistently sleeping less than 7 hours is a direct hormonal tax.
Resistance training, particularly compound movements involving large muscle groups (squats, deadlifts, rows, presses), acutely elevates testosterone and growth hormone and, with consistent practice, supports higher baseline levels. The effect is modest compared to sleep and body composition, but cumulative over years. More importantly, resistance training is directly anabolic — it builds the tissue that testosterone is meant to build, making whatever testosterone is available more effective.
Body composition is the highest-use modifiable variable for many men. As discussed above, excess adipose tissue drives aromatization. Getting from 25% to 12% body fat can produce testosterone increases of 10–20% in research settings without any other intervention. The mechanism is real and powerful.
Micronutrient status matters for testosterone synthesis. Zinc is a cofactor in testosterone production — deficiency is associated with significantly reduced testosterone, and supplementation in deficient men produces meaningful increases. Vitamin D functions more like a hormone than a vitamin; its receptor is present in testicular Leydig cells, and men with sufficient vitamin D status carry higher testosterone than deficient men. Magnesium deficiency impairs sleep and directly affects testosterone synthesis. None of these are magic bullets, but deficiency is a genuine limiter that routine optimization addresses.
Alcohol suppresses testosterone through multiple mechanisms including direct Leydig cell toxicity, increased SHBG, and sleep disruption. The dose-response is dose-dependent, but even moderate regular consumption has measurable effects on hormonal profiles in men. No secret here — alcohol works against anyone trying to optimize testosterone.
The Conversation With Your Doctor: A Tactical Guide
Most men approach their physician appointment hoping to be told everything is fine. The men who actually get answers go in knowing what they want and prepared to advocate for it.
Before the appointment, write down symptoms with approximate onset and severity. Fatigue that has worsened over the past two years is more clinically meaningful than a vague “feeling off.” Reduced libido dated to a specific period is actionable information. Difficulty recovering from workouts that was previously easier is data. Physicians respond to specific, temporal, measurable symptom descriptions more than generalized complaints.
Bring a written panel request with all nine markers listed by name. Hand it to the physician. This makes it a conversation about specific markers rather than a negotiation about whether the symptoms are “sick enough” to warrant testing. This isn’t a request for treatment — it’s a request for information about one’s own body.
If the physician pushes back on individual markers, have a rationale ready. Prolactin: “I want to rule out a pituitary adenoma as a contributing factor.” LH/FSH: “I want to understand whether the issue is testicular or upstream — this distinction affects the clinical approach.” DHEA-S: “I want to assess adrenal function as a contributing variable.” These are all legitimate clinical rationales, not biohacking requests.
If the physician refuses the full panel without adequate clinical justification, two options remain: direct-to-consumer lab ordering for the markers they won’t order, or a physician who practices evidence-based male medicine. Both are legitimate choices. Hormonal health is not something to outsource to someone who doesn’t prioritize it.
What Optimal Actually Looks Like
The Bhasin 2018 guidelines don’t provide a specific “optimal” range, because clinical guidelines are designed for disease treatment, not optimization. But the emerging functional medicine and men’s health literature, along with clinical experience from practitioners like Khera, Morgentaler, and Rouzier, generally describes optimal male hormonal function as approximately: total testosterone 600–900 ng/dL, free testosterone 15–25 pg/mL (when measured by equilibrium dialysis), SHBG 20–40 nmol/L, estradiol 20–30 pg/mL, LH and FSH in the lower half of the normal range (suggesting adequate but not desperate HPG signaling), prolactin below 10 ng/mL, DHEA-S appropriate for age (upper third of age-specific range), and AM cortisol 8–14 mcg/dL.
These targets should be read as directional, not absolute. Individual variation in hormone sensitivity — driven by androgen receptor density and sensitivity, which standard blood tests don’t measure — means one man functions excellently at 600 ng/dL while another feels suboptimal at 800 ng/dL. The blood values are data points. Lived experience is also data. Both should inform the clinical picture.
Common Questions About Hormone Panel Men
- Can I test at home instead of going to a lab? At-home testosterone tests exist and have improved in accuracy, but they measure only total testosterone and are not a substitute for a full nine-marker panel. Use them for convenient monitoring once an established baseline exists from a clinical lab, not for initial diagnosis.
- My doctor says my testosterone is “low-normal” and I’m fine. Should I push back? Yes, especially with symptoms present. “Low-normal” total testosterone with symptomatic presentation warrants a full panel including free testosterone and SHBG. Normal total testosterone can coexist with low free testosterone due to elevated SHBG — a condition that won’t be caught without the complete picture.
- How much does a full male hormone panel cost out of pocket? Through direct-to-consumer services like Ulta Lab Tests, a comprehensive nine-marker panel typically costs $150–300 depending on which tests are included and whether LabCorp or Quest facilities are used. Through insurance with a physician order, costs vary enormously based on plan and whether tests are deemed medically necessary.
- What time of day should I test and does it really matter that much? Yes, it genuinely matters. Testosterone peaks in the morning (7–10 AM) and declines through the day. Testing at noon instead of 8 AM can produce results 20–25% lower. Always test in the morning, fasted, consistently at the same time of day for comparable results across tests.
- Is it normal for testosterone to decline with age and should I just accept it? Testosterone does decline with age — roughly 1–2% per year after age 30. But the trajectory isn’t fixed. Sleep quality, body composition, resistance training, stress management, and micronutrient status all modulate the rate of decline. Many men maintain healthy testosterone levels well into their 50s and 60s with consistent attention to these variables. Acceptance is not the only option.
- Should I be concerned if my estradiol is high? Elevated estradiol in men (above 40 pg/mL) warrants attention, particularly if paired with symptoms like reduced libido, water retention, or mood changes. The priority is identifying the driver — excess body fat, alcohol, genetic aromatase overactivity, or medications that increase aromatization. Addressing the driver is more sustainable than symptom management.
- What’s the difference between bioidentical hormones and synthetic ones? Bioidentical hormones are chemically identical to the hormones the body produces — the testosterone used in TRT prescriptions is bioidentical (testosterone cypionate, enanthate, propionate are all bioidentical to endogenous testosterone). The “bioidentical vs synthetic” debate is largely a marketing distinction rather than a meaningful clinical one for testosterone specifically. What matters is route of administration, dose, and monitoring protocol.
- If my numbers are borderline, should I try lifestyle interventions first? Almost always yes, for 3–6 months with consistent effort, before considering clinical interventions. Sleep optimization, body composition improvement, stress management, and micronutrient correction can produce meaningful hormonal improvements in many men. There’s also much more certainty, after exhausting lifestyle options, about whether a genuine endocrine issue exists versus a lifestyle-driven hormonal suppression.
The clinical takeaway
Marcus eventually got his answer. Elevated SHBG was the primary culprit, driven by years of caloric restriction from aggressive dieting and probably some genetic predisposition. His free testosterone was roughly one-third of where it should have been despite “normal” total levels. With targeted interventions — eating more, lifting heavy, sleeping consistently, dropping the alcohol habit that had crept in — his free testosterone improved significantly over six months. He didn’t need TRT. He needed information his physician hadn’t been equipped to give him.
That’s the recurring theme in male hormonal health. The information is available. The tests exist. The interpretation framework is established. The obstacle is usually a healthcare system designed to treat disease rather than optimize function, combined with patients who don’t know what to ask for.
Now the questions are known. Nine markers, morning fasted draw, at least two confirmatory tests for anything significant, and the pattern-based interpretation framework that separates the story from the noise. Get the baseline. Know the numbers. Stop accepting “normal” as sufficient when symptoms are present and optimal is available.
The difference between normal and optimal is the difference between functioning and thriving. Normal is a statistical artifact. Optimal is a biological reality. Know which one you’re settling for.
Beyond the Panel: Contextual Markers That Round Out the Picture
The nine-marker male hormone panel is the core. But for a truly complete hormonal and metabolic picture, several additional tests provide important context that changes how the hormonal data should be interpreted.
Thyroid function — at minimum TSH, and ideally free T3, free T4, and thyroid antibodies (TPO Ab, Tg Ab) — belongs adjacent to any comprehensive hormonal evaluation. Hypothyroidism is common in men (though less common than in women) and can masquerade as low testosterone: fatigue, weight gain, cognitive sluggishness, reduced libido, and depressed mood. TSH alone misses subclinical hypothyroidism in many cases because TSH can remain “normal” while free T3 (the active thyroid hormone) is suboptimal. Hyperthyroidism, conversely, elevates SHBG — which as noted above reduces bioavailable testosterone independent of total testosterone production.
Insulin and fasting glucose complete the metabolic picture. Insulin resistance — the most prevalent metabolic condition in Western men — drives SHBG down, aromatization up, and testosterone down through multiple pathways. A fasting insulin above 10 mIU/L alongside low testosterone is a flashing arrow pointing toward metabolic dysfunction as the primary driver. Addressing insulin resistance through diet and activity changes the hormonal environment more fundamentally than any targeted hormonal intervention.
Complete blood count (CBC) during TRT monitoring adds hematocrit and hemoglobin tracking, since exogenous testosterone stimulates erythropoiesis. Men with hematocrit above 52–54% on TRT face elevated risk for thromboembolic events (blood clots). Regular monitoring and dose adjustment or therapeutic phlebotomy when needed keeps this risk manageable. Not a reason to avoid TRT when it’s needed — a reason to be monitored properly while on it.
PSA (Prostate-Specific Antigen) is appropriate for men over 40 considering or already using TRT. The historical fear that testosterone causes prostate cancer has been largely debunked — the “saturation model” proposed by Abraham Morgentaler suggests the prostate becomes maximally sensitive to testosterone at relatively low levels, and additional testosterone above that threshold doesn’t meaningfully increase cancer risk. PSA monitoring during TRT, however, is still considered standard of care by the Bhasin 2018 guidelines as a precautionary measure, and baseline PSA before starting TRT is prudent.
IGF-1 (Insulin-Like Growth Factor 1) is the primary mediator of growth hormone effects and provides a stable proxy for GH status that doesn’t require the complex stimulation testing of GH itself. GH and testosterone are closely interrelated — growth hormone deficiency produces many of the same symptoms as testosterone deficiency, and the two systems interact. IGF-1 measurement adds meaningful information about the anabolic hormonal environment beyond testosterone specifically, particularly for men over 40 who may have declining GH alongside declining testosterone.
None of these additional markers are required for a first male hormone panel. They represent the next layer of investigation once the core nine-marker panel raises questions, or when the most comprehensive possible baseline is wanted before beginning a significant optimization program. The cost of a full metabolic and hormonal workup including all of the above through direct-to-consumer labs typically runs $300–500 — a number that looks different once the alternative gets factored in: years of suboptimal function compounding quietly while remaining officially “within normal limits.”
Interpreting Your Results Without a Medical Degree
The panel’s run. The results are sitting there. Here’s a structured approach to understanding what’s being looked at before any clinical consultation.
Start with the big four: total testosterone, free testosterone, SHBG, and estradiol. These tell the first-order hormonal story. If total testosterone is adequate (above 500 ng/dL), free testosterone is adequate (above 15 pg/mL by equilibrium dialysis, or above 100 pg/mL by standard calculation), SHBG is in range (20–40 nmol/L), and estradiol is appropriate (20–30 pg/mL), the primary sex hormone environment is likely functional. Symptoms in this context are more likely driven by thyroid, cortisol, sleep, or non-hormonal factors.
If total testosterone is low (below 400 ng/dL) or free testosterone is low, move to LH and FSH. High LH/FSH with low T is primary hypogonadism — a testicular problem. Low LH/FSH with low T is secondary hypogonadism — a hypothalamic-pituitary problem. This distinction is critical and completely changes the clinical approach. Then check prolactin. If prolactin is elevated above 20 ng/mL, this is the leading suspect for secondary hypogonadism and imaging is warranted.
Check DHEA-S relative to age-specific reference range. Very low DHEA-S (below the 25th percentile for age) combined with elevated AM cortisol suggests adrenal fatigue or chronic stress physiology — a pattern that responds to lifestyle intervention before hormonal intervention. Very high DHEA-S combined with elevated estradiol and other androgen excess markers warrants adrenal evaluation.
AM cortisol in context: above 20 mcg/dL suggests significant HPA axis activation. Below 5 mcg/dL raises the question of adrenal insufficiency (rare but serious). The middle range (6–19 mcg/dL) is normal, with most optimally-functioning men in the 8–14 mcg/dL range. Persistently high cortisol with low testosterone is a pattern that responds to stress management and sleep optimization, not hormone replacement.
Write the pattern down in plain language before any clinical appointment: “My total testosterone is borderline low at 380 ng/dL, my SHBG is elevated at 58 nmol/L which drives my free testosterone to 6 pg/mL, my LH is appropriately elevated at 6 IU/L suggesting my testes are trying to respond, my estradiol is normal, prolactin is normal, and my AM cortisol is elevated at 21 mcg/dL which may be contributing to testosterone suppression.” That plain-language summary transforms a list of numbers into a clinical story any physician can engage with productively.
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map